News
Pfizer invests £500m in gene therapy facility
Pfizer is investing an additional half billion dollars for the construction of its state-of-the-art gene therapy manufacturing facility in Sanford, North Carolina.
The company said...
Pfizer awards $2 in grants to tackle AMR and infectious diseases
The Pfizer Foundation has awarded 20 grants totalling $2 million to organisations tackling infectious diseases and antimicrobial resistance (AMR) in communities in Africa, Asia...
CARB-X grant sees Vaxxilon develop first prophylactic vaccine for crKP
Swiss synthetic vaccines specialist, Vaxxilon, has secured a grant of up to $1.4 million from CARB X to develop the first prophylactic vaccine for...
